Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $69.9200 (10.98%) ($69.9200 - $69.9200) on Tue. Nov. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.94% (three month average) | RSI | 29 | Latest Price | $69.9200(10.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -4.3% a day on average for past five trading days. | Weekly Trend | LGND declines -13.5% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IWM(44%) IWN(44%) IWO(43%) IWC(41%) SDY(39%) | Factors Impacting LGND price | LGND will decline at least -1.97% in a week (0% probabilities). VXX(-16%) UNG(-10%) UUP(-7%) TBT(-5%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.97% (StdDev 3.94%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $49.12(-29.75%) | Resistance Level | $82.26 | 5 Day Moving Average | $65.1(7.4%) | 10 Day Moving Average | $75.28(-7.12%) | 20 Day Moving Average | $82.26(-15%) | To recent high | -35.1% | To recent low | 13.1% | Market Cap | $1.124b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |